New Key Statistics Module, Z-Score and F-Score
NAS:ETON Key Ratios
Market Cap $ M | 117.30 |
Enterprise Value $ M | 104.41 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | 16.03 |
Price/Book | 8.68 |
Price/Sales | 3.73 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 31.00 |
EPS (TTM) $ | -0.26 |
Beneish M-Score | -2.78 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 60.40 |
y-y EBITDA Growth Rate % | -673.20 |
EV-to-EBIT | -14.75 |
EV-to-EBITDA | -17.27 |
PEG | -- |
Shares Outstanding M | 25.84 |
Net Margin (%) | -21.31 |
Operating Margin % | -20.00 |
Pre-tax Margin (%) | -20.35 |
Quick Ratio | 1.28 |
Current Ratio | 1.40 |
ROA % (ttm) | -21.32 |
ROE % (ttm) | -42.84 |
ROIC % (ttm) | -73.14 |
Dividend Yield % | -- |
Altman Z-Score | -0.31 |
ETON Number of Guru Trades
ETON Volume of Guru Trades
Gurus Latest Trades with NAS:ETON
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ETON is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Eton Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ETON
Total 0- 1